| Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management AMJ Wensing, DA Van De Vijver, G Angarano, B Åsjö, C Balotta, E Boeri, ... The Journal of infectious diseases 192 (6), 958-966, 2005 | 560 | 2005 |
| Transmission of HIV drug resistance and the predicted effect on current first-line regimens in Europe LM Hofstra, N Sauvageot, J Albert, I Alexiev, F Garcia, D Struck, ... Clinical infectious diseases 62 (5), 655-663, 2016 | 192 | 2016 |
| Natural pregnancies in HIV-serodiscordant couples receiving successful antiretroviral therapy P Barreiro, J del Romero, M Leal, V Hernando, R Asencio, C de Mendoza, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 43 (3), 324-326, 2006 | 167 | 2006 |
| Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach D Paraskevis, O Pybus, G Magiorkinis, A Hatzakis, AMJ Wensing, ... Retrovirology 6, 1-11, 2009 | 154 | 2009 |
| Evaluation of eight different bioinformatics tools to predict viral tropism in different human immunodeficiency virus type 1 subtypes C Garrido, V Roulet, N Chueca, E Poveda, A Aguilera, K Skrabal, ... Journal of clinical microbiology 46 (3), 887-891, 2008 | 147 | 2008 |
| The calculated genetic barrier for antiretroviral drug resistance substitutions is largely similar for different HIV-1 subtypes DA Van De Vijver, AMJ Wensing, G Angarano, B Åsjö, C Balotta, E Boeri, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 41 (3), 352-360, 2006 | 137 | 2006 |
| Impact of human immunodeficiency virus type 1 (HIV-1) genetic diversity on performance of four commercial viral load assays: LCx HIV RNA Quantitative, AMPLICOR HIV-1 MONITOR v1 … P Swanson, C de Mendoza, Y Joshi, A Golden, RL Hodinka, V Soriano, ... Journal of clinical microbiology 43 (8), 3860-3868, 2005 | 137 | 2005 |
| Main differences between the first and second waves of COVID-19 in Madrid, Spain V Soriano, P Ganado-Pinilla, M Sanchez-Santos, F Gómez-Gallego, ... International Journal of Infectious Diseases 105, 374-376, 2021 | 132 | 2021 |
| Dried blood spots perform well in viral load monitoring of patients who receive antiretroviral treatment in rural Tanzania A Johannessen, C Garrido, N Zahonero, L Sandvik, E Naman, SL Kivuyo, ... Clinical Infectious Diseases 49 (6), 976-981, 2009 | 124 | 2009 |
| Hepatitis delta is a major determinant of liver decompensation events and death in HIV-infected patients JV Fernández-Montero, E Vispo, P Barreiro, R Sierra-Enguita, ... Clinical Infectious Diseases 58 (11), 1549-1553, 2014 | 114 | 2014 |
| Prevalence of transmitted HIV-1 drug resistance and the role of resistance algorithms: data from seroconverters in the CASCADE collaboration from 1987 to 2003 B Masquelier, K Bhaskaran, D Pillay, R Gifford, E Balestre, LB Jørgensen, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 40 (5), 505-511, 2005 | 113 | 2005 |
| Integrase inhibitor (INI) genotypic resistance in treatment-naive and raltegravir-experienced patients infected with diverse HIV-1 clades T Doyle, DT Dunn, F Ceccherini-Silberstein, C De Mendoza, F Garcia, ... Journal of Antimicrobial Chemotherapy 70 (11), 3080-3086, 2015 | 98 | 2015 |
| Efficacy and safety of replacing lopinavir with atazanavir in HIV-infected patients with undetectable plasma viraemia: final results of the SLOAT trial V Soriano, P García-Gasco, E Vispo, A Ruiz-Sancho, F Blanco, ... Journal of Antimicrobial Chemotherapy 61 (1), 200-205, 2008 | 97 | 2008 |
| Broad phenotypic cross-resistance to elvitegravir in HIV-infected patients failing on raltegravir-containing regimens C Garrido, J Villacian, N Zahonero, T Pattery, F Garcia, F Gutierrez, ... Antimicrobial agents and chemotherapy 56 (6), 2873-2878, 2012 | 96 | 2012 |
| Prevalence of X4 tropic viruses in patients recently infected with HIV-1 and lack of association with transmission of drug resistance C de Mendoza, C Rodriguez, F García, JM Eiros, L Ruíz, E Caballero, ... Journal of antimicrobial chemotherapy 59 (4), 698-704, 2007 | 95 | 2007 |
| New findings in HCV genotype distribution in selected West European, Russian and Israeli regions V Kartashev, M Döring, L Nieto, E Coletta, R Kaiser, S Sierra, A Guerrero, ... Journal of Clinical Virology 81, 82-89, 2016 | 91 | 2016 |
| High concordance between HIV-1 drug resistance genotypes generated from plasma and dried blood spots in antiretroviral-experienced patients S Masciotra, C Garrido, AS Youngpairoj, A McNulty, N Zahonero, A Corral, ... Aids 21 (18), 2503-2511, 2007 | 90 | 2007 |
| Hepatitis C therapy with HCV NS5B polymerase inhibitors V Soriano, E Vispo, C de Mendoza, P Labarga, JV Fernandez-Montero, ... Expert opinion on pharmacotherapy 14 (9), 1161-1170, 2013 | 89 | 2013 |
| Correlation between human immunodeficiency virus type 1 (HIV-1) RNA measurements obtained with dried blood spots and those obtained with plasma by use of Nuclisens EasyQ HIV-1 … C Garrido, N Zahonero, A Corral, M Arredondo, V Soriano, C de Mendoza Journal of clinical microbiology 47 (4), 1031-1036, 2009 | 88 | 2009 |
| Dual antiretroviral therapy for HIV infection V Soriano, JV Fernandez-Montero, L Benitez-Gutierrez, C Mendoza, ... Expert opinion on drug safety 16 (8), 923-932, 2017 | 86 | 2017 |
Vicente SorianoUNIR - Health Sciences School & Medical Center, Madrid, SpainVerified email at unir.net
